Annual Cash & Cash Equivalents
$18.06 M
+$11.45 M+173.40%
December 31, 2023
Summary
- As of February 12, 2025, NPCE annual cash & cash equivalents is $18.06 million, with the most recent change of +$11.45 million (+173.40%) on December 31, 2023.
- During the last 3 years, NPCE annual cash & cash equivalents has fallen by -$8.33 million (-31.57%).
- NPCE annual cash & cash equivalents is now -31.57% below its all-time high of $26.39 million, reached on December 31, 2020.
Performance
NPCE Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$15.42 M
+$2.57 M+20.04%
September 30, 2024
Summary
- As of February 12, 2025, NPCE quarterly cash and cash equivalents is $15.42 million, with the most recent change of +$2.57 million (+20.04%) on September 30, 2024.
- Over the past year, NPCE quarterly cash and cash equivalents has increased by +$5.70 million (+58.67%).
- NPCE quarterly cash and cash equivalents is now -50.66% below its all-time high of $31.25 million, reached on June 30, 2021.
Performance
NPCE Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
NPCE Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +173.4% | +58.7% |
3 y3 years | -31.6% | +58.7% |
5 y5 years | +338.0% | +58.7% |
NPCE Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -5.9% | +173.4% | -19.6% | +171.1% |
5 y | 5-year | -31.6% | +338.0% | -50.7% | +171.1% |
alltime | all time | -31.6% | +338.0% | -50.7% | +171.1% |
NeuroPace Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $15.42 M(+20.0%) |
Jun 2024 | - | $12.84 M(-1.2%) |
Mar 2024 | - | $13.00 M(-28.0%) |
Dec 2023 | $18.06 M(+173.4%) | $18.06 M(+85.8%) |
Sep 2023 | - | $9.72 M(+23.7%) |
Jun 2023 | - | $7.86 M(+16.9%) |
Mar 2023 | - | $6.72 M(+1.7%) |
Dec 2022 | $6.61 M | $6.61 M(+16.1%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | $5.69 M(-0.2%) |
Jun 2022 | - | $5.70 M(-23.9%) |
Mar 2022 | - | $7.49 M(-61.0%) |
Dec 2021 | $19.19 M(-27.3%) | $19.19 M(-28.0%) |
Sep 2021 | - | $26.63 M(-14.8%) |
Jun 2021 | - | $31.25 M(+125.8%) |
Mar 2021 | - | $13.84 M(-47.6%) |
Dec 2020 | $26.39 M(+540.1%) | $26.39 M |
Dec 2019 | $4.12 M | - |
FAQ
- What is NeuroPace annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for NeuroPace?
- What is NeuroPace annual cash & cash equivalents year-on-year change?
- What is NeuroPace quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for NeuroPace?
- What is NeuroPace quarterly cash and cash equivalents year-on-year change?
What is NeuroPace annual cash & cash equivalents?
The current annual cash & cash equivalents of NPCE is $18.06 M
What is the all time high annual cash & cash equivalents for NeuroPace?
NeuroPace all-time high annual cash & cash equivalents is $26.39 M
What is NeuroPace annual cash & cash equivalents year-on-year change?
Over the past year, NPCE annual cash & cash equivalents has changed by +$11.45 M (+173.40%)
What is NeuroPace quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NPCE is $15.42 M
What is the all time high quarterly cash and cash equivalents for NeuroPace?
NeuroPace all-time high quarterly cash and cash equivalents is $31.25 M
What is NeuroPace quarterly cash and cash equivalents year-on-year change?
Over the past year, NPCE quarterly cash and cash equivalents has changed by +$5.70 M (+58.67%)